Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis
Phase 2
Withdrawn
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: TLL018Other: Placebo
- First Posted Date
- 2021-11-16
- Last Posted Date
- 2022-05-13
- Lead Sponsor
- TLL Pharmaceutical, LLC
- Registration Number
- NCT05121402
- Locations
- 🇺🇸
Gastroenterology Research of San Antonio (GERSA), San Antonio, Texas, United States
A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: TLL018 tablet, placebo
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2021-03-30
- Lead Sponsor
- TLL Pharmaceutical, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT04243083
- Locations
- 🇺🇸
Frontage Clinical Services, Inc., Secaucus, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath